|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
She J, Yang P, Hong Q and Bai C: Lung
cancer in China: Challenges and interventions. Chest.
143:1117–1126. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Thatcher N and Heighway J: Maintenance and
consolidation therapy in patients with unresectable stage III/IV
non-small cell lung cancer. Oncologist. 15:1034–1042. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sereno M, Rodriguez-Esteban I,
Gómez-Raposo C, Merino M, López-Gómez M, Zambrana F and Casado E:
Lung cancer and peritoneal carcinomatosis. Oncol Lett. 6:705–708.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hellmann MD, Li BT, Chaft JE and Kris MG:
Chemotherapy remains an essential element of personalized care for
persons with lung cancers. Ann Oncol. 27:1829–1835. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang J, Zhang J, Zhang L, Zhao L, Fan S,
Yang Z, Gao F, Kong Y, Xiao GG and Wang Q: Expression of P-gp, MRP,
LRP, GST-pi and TopoIIalpha and intrinsic resistance in human lung
cancer cell lines. Oncol Rep. 26:1081–1089. 2011.PubMed/NCBI
|
|
7
|
Wang XS, Zhang YJ, Liu XL, Zhou ZR, Hu CS
and Eisbruch A: The role of technetium-99m methoxyisobutyl
isonitrile scintigraphy in predicting the therapeutic effect of
chemotherapy against nasopharyngeal carcinoma. Cancer.
117:2435–2441. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kim SS, Seong S and Kim SY: Synergistic
effect of ginsenoside Rg3 with verapamil on the modulation of
multidrug resistance in human acute myeloid leukemia cells. Oncol
Lett. 7:1265–1269. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kwon HY, Kim EH, Kim SW, Kim SN, Park JD
and Rhee DK: Selective toxicity of ginsenoside Rg3 on multidrug
resistant cells by membrane fluidity modulation. Arch Pharm Res.
31:171–177. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sadava D and Kane SE: Silibinin reverses
drug resistance in human small-cell lung carcinoma cells. Cancer
Lett. 339:102–106. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gottesman MM, Fojo T and Bates SE:
Multidrug resistance in cancer: Role of ATP-dependent transporters.
Nature Rev Cancer. 2:48–58. 2002. View
Article : Google Scholar
|
|
12
|
Sharom FJ: The P-glycoprotein multidrug
transporter. Essays Biochem. 50:161–178. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Polgar O and Bates SE: ABC transporters in
the balance: Is there a role in multidrug resistance? Biochem Soc
Trans. 33:241–245. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Steinbach D and Legrand O: ABC
transporters and drug resistance in leukemia: Was P-gp nothing but
the first head of the Hydra? Leukemia. 21:1172–1176. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhu WY, Hunag YY, Liu XG, He JY, Chen DD,
Zeng F, Zhou JH and Zhang YK: Prognostic evaluation of CapG,
gelsolin, P-gp, GSTP1 and Topo-II proteins in non-small cell lung
cancer. Anat Rec (Hoboken). 295:208–214. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Borst P, Evers R, Kool M and Wijnholds J:
A family of drug transporters: The multidrug resistance-associated
proteins. J Natl Cancer Inst. 92:1295–1302. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Scheffer GL, Wijngaard PL, Flens MJ,
Izquierdo MA, Slovak ML, Pinedo HM, Meijer CJ, Clevers HC and
Scheper RJ: The drug resistance-related protein LRP is the human
major vault protein. Nat Med. 1:578–582. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Attele AS, Wu JA and Yuan CS: Ginseng
pharmacology: Multiple constituents and multiple actions. Biochem
Pharmacol. 58:1685–1693. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gillis CN: Panax ginseng pharmacology: A
nitric oxide link? Biochem Pharmacol. 54:1–8. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Molnar J, Szabo D, Pusztai R, Mucsi I,
Berek L, Ocsovszki I, Kawata E and Shoyama Y: Membrane associated
antitumor effects of crocine-, ginsenoside- and cannabinoid
derivates. Anticancer Res. 20:861–867. 2000.PubMed/NCBI
|
|
21
|
Geng L, Fan J, Gao QL, Yu J and Hua BJ:
Preliminary study for the roles and mechanisms of 20(R)-ginsenoside
Rg3 and PEG-PLGA-Rg3 nanoparticles in the Lewis lung cancer mice.
Beijing Da Xue Xue Bao Yi Xue Ban. 48:496–501. 2016.(In Chinese).
PubMed/NCBI
|
|
22
|
Zhang F, Li M, Wu X, Hu Y, Cao Y, Wang X,
Xiang S, Li H, Jiang L, Tan Z, et al: 20(S)-ginsenoside Rg3
promotes senescence and apoptosis in gallbladder cancer cells via
the p53 pathway. Drug Des Devel Ther. 9:3969–3987. 2015.PubMed/NCBI
|
|
23
|
Cheong JH, Kim H, Hong MJ, Yang MH, Kim
JW, Yoo H, Yang H, Park JH, Sung SH, Kim HP and Kim J:
Stereoisomer-specific anticancer activities of ginsenoside Rg3 and
Rh2 in HepG2 cells: Disparity in cytotoxicity and
autophagy-inducing effects due to 20(S)-epimers. Biol Pharm Bull.
38:102–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu T, Zhao L, Zhang Y, Chen W, Liu D, Hou
H, Ding L and Li X: Ginsenoside 20(S)-Rg3 targets HIF-1α to block
hypoxia-induced epithelial-mesenchymal transition in ovarian cancer
cells. PLoS One. 9:e1038872014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kim SW, Kwon HY, Chi DW, Shim JH, Park JD,
Lee YH, Pyo S and Rhee DK: Reversal of P-glycoprotein-mediated
multidrug resistance by ginsenoside Rg (3). Biochem Pharmacol.
65:75–82. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhu W, Xu H, Zhu D, Zhi H, Wang T, Wang J,
Jiang B, Shu Y and Liu P: miR-200bc/429 cluster modulates multidrug
resistance of human cancer cell lines by targeting BCL2 and XIAP.
Cancer Chemother Pharmacol. 69:723–731. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yamaue H, Tanimura H, Noguchi K, Hotta T,
Tani M, Tsunoda T, Iwahashi M, Tamai M and Iwakura S:
Chemosensitivity testing of fresh human gastric cancer with highly
purified tumour cells using the MTT assay. Br J Cancer. 66:794–799.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Loening AM and Gambhir SS: AMIDE: A free
software tool for multimodality medical image analysis. Mol
Imaging. 2:131–137. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Duan XY, Wang JS, Liu M and Guo YM:
Technetium-99m-hexakis-2-methoxyisobutylisonitrile scintigraphy and
multidrug resistance-related protein expression in human primary
lung cancer. Ann Nucl Med. 22:49–55. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang H, Wang L, Song L, Zhang YW, Ye J, Xu
RX, Shi N and Meng XM: TNNI3K is a novel mediator of myofilament
function and phosphorylates cardiac troponin I. Braz J Med Biol
Res. 46:128–137. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang L, Wang H, Ye J, Xu RX, Song L, Shi
N, Zhang YW, Chen X and Meng XM: Adenovirus-mediated overexpression
of cardiac troponin I-interacting kinase promotes cardiomyocyte
hypertrophy. Clin Exp Pharmacol Physiol. 38:278–284. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gao Y, Li W, Liu X, Gao F and Zhao X:
Reversing effect and mechanism of soluble resistance-related
calcium-binding protein on multidrug resistance in human lung
cancer A549/DDP cells. Mol Med Rep. 11:2118–2124. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang H, Chen Y, Lu XA, Liu G, Fu Y and Luo
Y: Endostatin prevents dietary-induced obesity by inhibiting
adipogenesis and angiogenesis. Diabetes. 64:2442–2456. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhou W and Christiani DC: East meets west:
Ethnic differences in epidemiology and clinical behaviors of lung
cancer between East Asians and caucasians. Chin J Cancer.
30:287–292. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li K, Chen B, Xu L, Feng J, Xia G, Cheng
J, Wang J, Gao F and Wang X: Reversal of multidrug resistance by
cisplatin-loaded magnetic Fe3O4 nanoparticles in A549/DDP lung
cancer cells in vitro and in vivo. Int J Nanomedicine. 8:1867–1877.
2013.PubMed/NCBI
|
|
37
|
Yan LH, Wei WY, Cao WL, Zhang XS, Xie YB
and Xiao Q: Overexpression of E2F1 in human gastric carcinoma is
involved in anti-cancer drug resistance. BMC Cancer. 14:9042014.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kang JH, Lee SI, Lim DH, Park KW, Oh SY,
Kwon HC, Hwang IG, Lee SC, Nam E, Shin DB, et al: Salvage
chemotherapy for pretreated gastric cancer: A randomized phase III
trial comparing chemotherapy plus best supportive care with best
supportive care alone. J Clin Oncol. 30:1513–1518. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Montagnani F, Turrisi G, Marinozzi C,
Aliberti C and Fiorentini G: Effectiveness and safety of
oxaliplatin compared to cisplatin for advanced, unresectable
gastric cancer: A systematic review and meta-analysis. Gastric
Cancer. 14:50–55. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ohe Y, Ohashi Y, Kubota K, Tamura T,
Nakagawa K, Negoro S, Nishiwaki Y, Saijo N, Ariyoshi Y and Fukuoka
M: Randomized phase III study of cisplatin plus irinotecan versus
carboplatin plus paclitaxel, cisplatin plus gemcitabine and
cisplatin plus vinorelbine for advanced non-small-cell lung cancer:
Four-Arm cooperative study in Japan. Ann Oncol. 18:317–323. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Chung AS, Wu X, Zhuang G, Ngu H, Kasman I,
Zhang J, Vernes JM, Jiang Z, Meng YG, Peale FV, et al: An
interleukin-17-mediated paracrine network promotes tumor resistance
to anti-angiogenic therapy. Nat Med. 19:1114–1123. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kawakami M, Nakamura T, Okamura N, Komoto
C, Markova S, Kobayashi H, Hashimoto N, Okumura K and Sakaeda T:
Knock-down of sorcin induces up-regulation of MDR1 in HeLa cells.
Biol Pharm Bull. 30:1065–1073. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Akazawa Y, Kawaguchi H, Funahashi M,
Watanabe Y, Yamaoka K, Hashida M and Takakura Y: Effect of
interferons on P-glycoprotein-mediated rhodamine-123 efflux in
cultured rat hepatocytes. J Pharm Sci. 91:2110–2115. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Toner AP, McLaughlin F, Giles FJ, Sullivan
FJ, O'Connell E, Carleton LA, Breen L, Dunne G, Gorman AM, Lewis JD
and Glynn SA: The novel toluidine sulphonamide EL102 shows
pre-clinical in vitro and in vivo activity against prostate cancer
and circumvents MDR1 resistance. Br J Cancer. 109:2131–2141. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Tajitsu Y, Ikeda R, Nishizawa Y, Mataki H,
Che XF, Sumizawa T, Nitta M, Yamaguchi T, Yamamoto M, Tabata S, et
al: Molecular basis for the expression of major vault protein
induced by hyperosmotic stress in SW620 human colon cancer cells.
Int J Mol Med. 32:703–708. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Keppler D: Multidrug resistance proteins
(MRPs, ABCCs): Importance for pathophysiology and drug therapy.
Handb Exp Pharmacol. 1–323. 2011.
|
|
47
|
Tognon G, Bernasconi S, Celli N, Faircloth
GT, Cuevas C, Jimeno J, Erba E and D'Incalci M: Induction of
resistance to Aplidin in a human ovarian cancer cell line related
to MDR expression. Cancer Biol Ther. 4:1325–1330. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Jin L, Xu M, Luo XH and Zhu XF: Stephania
tetrandra and ginseng-containing chinese herbal formulation NSENL
reverses cisplatin resistance in lung cancer xenografts. Am J Chin
Med. 45:385–401. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Mubashar M, Harrington KJ, Chaudhary KS,
Lalani el-N, Stamp GW, Sinnett D, Glass DM and Peters AM:
99mTc-sestamibi imaging in the assessment of toremifene as a
modulator of multidrug resistance in patients with breast cancer. J
Nucl Med. 43:519–525. 2002.PubMed/NCBI
|
|
50
|
Saggiorato E, Angusti T, Rosas R,
Martinese M, Finessi M, Arecco F, Trevisiol E, Bergero N,
Puligheddu B, Volante M, et al: 99mTc-MIBI imaging in the
presurgical characterization of thyroid follicular neoplasms:
Relationship to multidrug resistance protein expression. J Nucl
Med. 50:1785–1793. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Piwnica-Worms D, Chiu ML, Budding M,
Kronauge JF, Kramer RA and Croop JM: Functional imaging of
multidrug-resistant P-glycoprotein with an organotechnetium
complex. Cancer Res. 53:977–984. 1993.PubMed/NCBI
|
